Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yumi Nonomura, Atsushi Otsuka, Chisa Nakashima, Judith A. Seidel, Akihiko Kitoh, Teruki Dainichi, Saeko Nakajima, Yu Sawada, Shigeto Matsushita, Megumi Aoki, Tatsuya Takenouchi, Taku Fujimura, Naohito Hatta, Satoshi Koreeda, Satoshi Fukushima, Tetsuya Honda & Kenji Kabashima. (2016) Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients. OncoImmunology 5:12.
Read now
Read now
Articles from other publishers (22)
Salvatore Maugeri, Jay Sibbitts, Anna Privitera, Vincenzo Cardaci, Lucia Di Pietro, Loredana Leggio, Nunzio Iraci, Susan M. Lunte & Giuseppe Caruso. (2023) The Anti-Cancer Activity of the Naturally Occurring Dipeptide Carnosine: Potential for Breast Cancer. Cells 12:22, pages 2592.
Crossref
Crossref
Changsen Yang, Tiangang Song, Yajie Mo, Peixuan Wu, Haokun Tian, Lequan Wen & Yun Gao. (2023) Association of CCL4 rs10491121 and rs1634507 gene polymorphisms with cancer susceptibility: trial sequential analysis and meta-analysis. Frontiers in Oncology 13.
Crossref
Crossref
Muzaffar H. QazilbashNeeraj Y. SainiSoung-chul ChaZhe WangEdward A. StadtmauerVeerabhadran Baladandayuthapani, Heather Lin, Beryl TrossMedhavi HonharSheetal S. Rao, Kunhwa Kim, Michael Popescu, Szymon SzymuraTiantian ZhangAaron AndersonQaiser Bashir, Elizabeth J. ShpallRobert Z. Orlowski, Bruce L. Levine, Naseem KerrAlfred Garfall, Adam Cohen, Dan T. Vogl, Karen DengelCarl H. JuneRichard Champlin & Larry W. Kwak. (2022) A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma. Blood 139:9, pages 1289-1301.
Crossref
Crossref
Alexander H. Lee, Lu Sun, Aaron Y. Mochizuki, Jeremy G. Reynoso, Joey Orpilla, Frances Chow, Jenny C. Kienzler, Richard G. Everson, David A. Nathanson, Steven J. Bensinger, Linda M. Liau, Timothy Cloughesy, Willy Hugo & Robert M. Prins. (2021) Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. Nature Communications 12:1.
Crossref
Crossref
Xin Wang, Yong Han, Jiamin Peng & Jie He. (2021) CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer. Aging 13:20, pages 23810-23830.
Crossref
Crossref
Monica D. Prakash, Sarah Fraser, Jennifer C. Boer, Magdalena Plebanski, Barbora de Courten & Vasso Apostolopoulos. (2021) Anti-Cancer Effects of Carnosine—A Dipeptide Molecule. Molecules 26:6, pages 1644.
Crossref
Crossref
Ana Martín‐Leal, Raquel Blanco, Josefina Casas, María E Sáez, Elena Rodríguez‐Bovolenta, Itziar de Rojas, Carina Drechsler, Luis Miguel Real, Gemma Fabrias, Agustín Ruíz, Mario Castro, Wolfgang WA Schamel, Balbino Alarcón, Hisse M van Santen & Santos Mañes. (2020)
CCR
5 deficiency impairs
CD
4
+
T‐cell memory responses and antigenic sensitivity through increased ceramide synthesis
. The EMBO Journal 39:15.
Crossref
Crossref
Kenneth H. Hu, John P. Eichorst, Chris S. McGinnis, David M. Patterson, Eric D. Chow, Kelly Kersten, Stephen C. Jameson, Zev J. Gartner, Arjun A. Rao & Matthew F. Krummel. (2020) ZipSeq: barcoding for real-time mapping of single cell transcriptomes. Nature Methods 17:8, pages 833-843.
Crossref
Crossref
Asmaa M. Zahran, Helal F. Hetta, Amal Rayan, Abeer Sharaf Eldin, Elham Ahmed Hassan, Hussein Fakhry, Ahmed Soliman & Omnia El-Badawy. (2020) Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes. Cancer Immunology, Immunotherapy 69:7, pages 1253-1263.
Crossref
Crossref
Santosh K. Singh, Manoj K. Mishra, Brian M. Rivers, Jennifer B. Gordetsky, Sejong Bae & Rajesh Singh. (2020) Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma. Cancers 12:4, pages 883.
Crossref
Crossref
Yeo Song Lee & Yong Beom Cho. 2020. Tumor Microenvironment. Tumor Microenvironment
33
43
.
Minjun Yu, Iris Scherwitzl, Silvana Opp, Aristotelis Tsirigos & Daniel Meruelo. (2019) Molecular and metabolic pathways mediating curative treatment of a non-Hodgkin B cell lymphoma by Sindbis viral vectors and anti-4-1BB monoclonal antibody. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Luis Fernando L. Mangieri, Michelle M. Sena, Fernando Cezar‐dos‐Santos, Kleber P. Trugilo, Nádia C. M. Okuyama, Érica R. Pereira, Gabriela C. Q. Maria, Maria Angelica E. Watanabe & Karen B. Oliveira. (2019)
CCR5
genetic variants and epidemiological determinants for HPV infection and cervical premalignant lesions
. International Journal of Immunogenetics 46:5, pages 331-338.
Crossref
Crossref
Faria Fatima, Saima Saleem, Abdul Hameed, Ghulam Haider, Syed Aqib Ali Zaidi, Madiha Kanwal, Sitwat Zehra & Abid Azhar. (2019) Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan. Molecular Biology Reports 46:2, pages 2387-2394.
Crossref
Crossref
Valeria Mollica Poeta, Matteo Massara, Arianna Capucetti & Raffaella Bonecchi. (2019) Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy. Frontiers in Immunology 10.
Crossref
Crossref
Ming-Yu Lien, Chiao-Wen Lin, Hsiao-Chi Tsai, Yng-Tay Chen, Ming-Hsui Tsai, Chun-Hung Hua, Shun-Fa Yang & Chih-Hsin Tang. (2017) Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics. Oncotarget 8:19, pages 31424-31434.
Crossref
Crossref
R.A. Lacalle, R. Blanco, L. Carmona-Rodríguez, A. Martín-Leal, E. Mira & S. Mañes. 2017.
181
244
.
Niels Halama, Inka Zoernig, Anna Berthel, Christoph Kahlert, Fee Klupp, Meggy Suarez-Carmona, Thomas Suetterlin, Karsten Brand, Juergen Krauss, Felix Lasitschka, Tina Lerchl, Claudia Luckner-Minden, Alexis Ulrich, Moritz Koch, Juergen Weitz, Martin Schneider, Markus W. Buechler, Laurence Zitvogel, Thomas Herrmann, Axel Benner, Christina Kunz, Stephan Luecke, Christoph Springfeld, Niels Grabe, Christine S. Falk & Dirk Jaeger. (2016) Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. Cancer Cell 29:4, pages 587-601.
Crossref
Crossref
Yuan-Ya Liao, Hsiao-Chi Tsai, Pei-Yu Chou, Shih-Wei Wang, Hsien-Te Chen, Yu-Min Lin, I-Ping Chiang, Tzu-Ming Chang, Shao-Keh Hsu, Ming-Chih Chou, Chih-Hsin Tang & Yi-Chin Fong. (2015) CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells. Oncotarget 7:4, pages 4310-4325.
Crossref
Crossref
M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz & A Mehrabi. (2015) Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. British Journal of Cancer 113:5, pages 756-762.
Crossref
Crossref
Carlos Eduardo Coral de Oliveira, Julie Massayo Maeda Oda, Roberta Losi Guembarovski, Karen Brajão de Oliveira, Carolina Batista Ariza, Jamil Soni Neto, Bruna Karina Banin Hirata & Maria Angelica Ehara Watanabe. (2014) CC Chemokine Receptor 5: The Interface of Host Immunity and Cancer. Disease Markers 2014, pages 1-8.
Crossref
Crossref
D Bedognetti, T L Spivey, Y Zhao, L Uccellini, S Tomei, M E Dudley, M L Ascierto, V De Giorgi, Q Liu, L G Delogu, M Sommariva, M R Sertoli, R Simon, E Wang, S A Rosenberg & F M Marincola. (2013) CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British Journal of Cancer 109:9, pages 2412-2423.
Crossref
Crossref